Legal & General Group
STIM icon

Legal & General Group’s Neuronetics STIM Stock Holding History

Legal & General Group’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.79K Sell
3,294
-736
-18% -$1.17K ﹤0.01% 3292
2025
Q4 		$5.56K Hold
4,030
– – ﹤0.01% 3333
2025
Q3 		$11K Hold
4,030
– – ﹤0.01% 3265
2025
Q2 		$14.1K Buy
+4,030
New +$15.9K ﹤0.01% 3155
2022
Q3 		– Sell
-1,993
Closed -$6K – 3486
2022
Q2 		$6K Sell
1,993
-581
-23% -$1.69K ﹤0.01% 3434
2022
Q1 		$8K Hold
2,574
– – ﹤0.01% 3452
2021
Q4 		$11K Hold
2,574
– – ﹤0.01% 3445
2021
Q3 		$17K Hold
2,574
– – ﹤0.01% 3336
2021
Q2 		$41K Buy
+2,574
New +$35.6K ﹤0.01% 3010
2020
Q2 		– Sell
-2,691
Closed -$5K – 3459
2020
Q1 		$5K Hold
2,691
– – ﹤0.01% 3270
2019
Q4 		$12K Buy
2,691
+531
+25% +$3.3K ﹤0.01% 3270
2019
Q3 		$18K Hold
2,160
– – ﹤0.01% 3172
2019
Q2 		$24K Hold
2,160
– – ﹤0.01% 3131
2019
Q1 		$33K Buy
2,160
+1,190
+123% +$19.7K ﹤0.01% 2890
2018
Q4 		$19K Hold
970
– – ﹤0.01% 3105
2018
Q3 		$31K Buy
+970
New +$29.5K ﹤0.01% 3009

Other funds holding STIM

MAM
Madryn Asset Management New York $34.1M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Legal & General Group's STIM Position: Q1 2026 in Review

Legal & General Group reduced its Neuronetics (STIM) stake by 18% in Q1 2026, selling an estimated $1.17K and leaving 3,294 shares worth $4.79K. The position accounts for ﹤0.01% of the portfolio, ranked #3292.

Legal & General Group first reported a position in STIM in Q3 2018 and has held it in 16 quarters since. The position peaked at $41K in Q2 2021. 99 funds tracked by Wall St. Rank hold STIM as of Q1 2026.

  • Legal & General Group held 3,294 shares of Neuronetics worth $4.79K as of Q1 2026.
  • Legal & General Group sold 736 Neuronetics shares in Q1 2026, an estimated $1.17K.
  • Neuronetics made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #3292 holding.
  • Legal & General Group first reported a position in Neuronetics in Q3 2018 and has held it in 16 quarters since.
  • Legal & General Group's Neuronetics position peaked at $41K in Q2 2021.
  • 99 funds tracked by Wall St. Rank held Neuronetics as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.